HSBC Holdings’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,091
Closed -$366K 2870
2023
Q1
$366K Hold
25,091
﹤0.01% 2157
2022
Q4
$183K Hold
25,091
﹤0.01% 2791
2022
Q3
$178K Hold
25,091
﹤0.01% 2656
2022
Q2
$175K Hold
25,091
﹤0.01% 2920
2022
Q1
$202K Buy
+25,091
New +$226K ﹤0.01% 2992

HSBC Holdings's AMYT Position: Q2 2023 in Review

HSBC Holdings sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 25,091 shares — an estimated $366K sold.

HSBC Holdings first reported a position in AMYT in Q1 2022 and held it in 5 quarters. The position peaked at $366K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • HSBC Holdings reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • HSBC Holdings sold 25,091 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $366K.
  • HSBC Holdings first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2022 and held it in 5 quarters.
  • HSBC Holdings's Amryt Pharma plc American Depositary Shares position peaked at $366K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on HSBC Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.